---
title: "Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290830861.md"
description: "Walgreens, based in Deerfield, Illinois, is launching the Medicare GLP-1 Bridge program to assist over 56 million patients in the Medicare network who could qualify for GLP-1 medications. This initiative will be available at nearly 8,000 Walgreens stores nationwide. Eligible Medicare patients can consult Walgreens pharmacists to guide them through the program. To participate, patients are advised to discuss potential eligibility with their healthcare provider. The Medicare Bridge program aims to streamline access to GLP-1 medications for qualifying individuals across the United States."
datetime: "2026-06-25T12:04:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290830861.md)
  - [en](https://longbridge.com/en/news/290830861.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290830861.md)
generator: "portal-rs"
---

# Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications

Walgreens, based in Deerfield, Illinois, is launching the Medicare GLP-1 Bridge program to assist over 56 million patients in the Medicare network who could qualify for GLP-1 medications. This initiative will be available at nearly 8,000 Walgreens stores nationwide. Eligible Medicare patients can consult Walgreens pharmacists to guide them through the program. To participate, patients are advised to discuss potential eligibility with their healthcare provider. The Medicare Bridge program aims to streamline access to GLP-1 medications for qualifying individuals across the United States.

### Related Stocks

- [WBA.US](https://longbridge.com/en/quote/WBA.US.md)

## Related News & Research

- [New Medicare and Medicaid GLP-1 Programs Spotlight Lifestyle Support as Menu-Order AI Launches Daily GLP-1 Habit Tracker, Helping Users Stay on Track](https://longbridge.com/en/news/298990827.md)
- [JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk](https://longbridge.com/en/news/298770772.md)
- [Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss](https://longbridge.com/en/news/298988404.md)
- [J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?](https://longbridge.com/en/news/298771060.md)
- [Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®](https://longbridge.com/en/news/298806059.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**